A Review on Novel Drug Delivery System: A Recent Trend by Bandawane, Akash & Saudagar, Ravindranath
Bandawane et al                                                                                                   Journal of Drug Delivery & Therapeutics. 2019; 9(3):517-521 
ISSN: 2250-1177                                                                                    [517]                                                                                    CODEN (USA): JDDTAO 
Available online on 15.05.2019 at http://jddtonline.info 
Journal of Drug Delivery and Therapeutics 
Open Access to Pharmaceutical and Medical Research 
© 2011-18, publisher and licensee JDDT, This is an Open Access article which permits unrestricted 
non-commercial use, provided the original work is properly cited 
Open  Access                                                                                                                                                               Review Article 
A Review on Novel Drug Delivery System: A Recent Trend 
Bandawane Akash1*, Saudagar Ravindranath1 
1 Department of Pharmaceutical Quality assurance, R.G. Sapkal College of Pharmacy, Anjaneri,  Nashik , Maharashtra, India- 422 213 
2 Department of Pharmaceutical Chemistry, R.G Sapkal College of Pharmacy, Anjaneri, Nashik-422213, Maharashtra, India. 
 
ABSTRACT 
Plants are nature’s remedies and have been used by human beings on earth since ancient times for food and medicine. Today there are global 
movements towards finding of herbal medicaments in plants to bring them in market via a suitable drug delivery system for mankind. The basic 
thought behind it is treatment of each disease is hidden in nature. However, delivery of herbal drugs also requires modification with the 
purpose to achieve sustain release, to increase patient compliance etc. previously herbal drugs could not attract scientists towards the 
modifications of novel drug delivery systems due to processing, standardizing, extracting and identification difficulties. But now days with the 
advancement in the technology, novel drug delivery systems (NDDS) open the door towards the development of herbal novel drug delivery 
system. With use of advance techniques protection from toxicity, enhancement in stability, improved bioavailability of herbal  formulations, 
protection from physical and chemical degradation can be achieve. Novel drug delivery technologies have gained the importance to achieve 
modified delivery of herbal drugs their by increasing the therapeutic value as well as reducing toxicity. The present reviews gives information 
regarding various novel techniques used for improving safety and efficacy of phytomedicines and application of novel formulation. The main 
goal for developing such delivery systems is to minimize drug degradation and loss, to prevent harmful side effects and to increase 
bioavailability. Targeting is the ability to direct the drug loaded system to the site of interest. Among drug carrier one can name soluble 
polymers, microparticles made of insoluble (or) biodegradable natural and synthetic polymers, microcapsules, cells, cell ghosts, lipoproteins, 
liposomes and micelles. Two major mechanisms can be distinguished for addressing the desired sites for drug release, (a) Passive and (b) 
Active targeting. Controlled drug carrier systems such as micellar solutions, vescicles and liquid crystal dispersions, as well as nanoparticle 
dispersions consisting of small particles of 10 – 400 nm show great promise as drug delivery systems. Hydrogels are three dimensional, 
hydrophilic, polymer networks capable of imbibing large amounts of water or biological fluids. 
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Herbal formulation means a dosage form consisting of one or 
more herbs or processed herbs in specified quantities to 
provide specific nutritional, cosmetic benefits, and/or other 
benefits. Herbal preparations are obtained by subjecting 
whole plant, fragmented or cut plants, plants parts to 
treatments such as distillation, extraction, expression, 
fractionation, purification, concentration or fermentation. 
These include comminuted or powdered herbal substances, 
tinctures, extracts, essential oils, expressed juices and 
processed exudates 1. Herbal drug itself is complex structure 
of many active constituents; as all of them provide 
synergistic action and enhance the therapeutic value 2. 
Herbal drugs have lesser side effects 3,4. 
Novel drug delivery systems can include those based on 
physical mechanisms and those based on biochemical 
mechanisms. Physical mechanisms also referred as 
controlled drug delivery systems include osmosis, diffusion, 
erosion, dissolution and electro transport. Biochemical 
mechanisms include monoclonal antibodies, gene therapy, 
and vector systems, polymer drug adducts and liposomes. 
Targeting is the ability to direct the drug-loaded system to 
the site of interest. Two major mechanisms can be 
distinguished for addressing the desired sites for drug 
release: (i) Passive and (ii) Active targeting. 
Therapeutic benefits of some new drug delivery systems 
include optimization of duration of action of drug, decreasing 
dosage frequency, controlling the site of release and 
maintaining constant drug Levels 5,6,7 
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ADVANTAGES OF NOVEL DRUG DELIVERY SYSTEM  
1. Protection from physical and chemical degradation.  
2. Sustained delivery.  
3. Improved tissue macrophages distribution.  
4. Enhancement of stability.  
5. Enhancement of pharmacological activity.  
6. Protection from toxicity.  
7. Increased bioavailability.  
8. Enhancement of solubility 8.  
RECENT DEVELOPMENTS IN NOVEL DRUG 
DELIVERY SYSTEM OF HERBALS  
1. Phytosome 
2. Liposome  
3. Nanoparticles  
4. Emulsions  
5. Microsphere  
6. Ethosome 
7. Solid lipid nanopartical 
8. Niosomes 
9. Proniosomes 
10. Transdermal Drug Delivery System  
11. Dendrimers  
12. Liquid Crystals  
13. Hydrogels 9 
PHYTOSOMES 
Phytosomes are lipid compatible molecular complex which 
are composed of “phyto” which means plant and “some” 
meaning cell-like 10. Complexing the polyphenolic 
phytoconstituents in the molar ratio with phosphatidyl 
choline results in a new herbal drug delivery system, known 
as “Phytosome”. Phytosomes are advanced forms of herbal 
products that are better absorbed, utilized to produce better 
results than those produced by conventional herbal extracts. 
Phytosomes show better pharmacokinetic and therapeutic 
profiles than conventional herbal extracts 11.  
Advantages of phytosome 
1. Phytosome increases the absorption of active 
constituents, so its dose size required is small.  
2. There is appreciable drug entrapment and 
improvement in the solubility of bile to herbal 
constituents, and it can target the liver.  
3. In Phytosome, chemical bonds are formed between 
phosphatidylcholine molecules, so it shows good 
stability 12.  
4. Phytosome improves the percutaneous absorption of 
herbal phytoconstituents 13 
LIPOSOMES 
Tiny pouches made of lipids, or fat molecules surrounding a 
water core widely used for clinical cancer treatment. Several 
different kinds of liposomes are widely employed against 
infectious diseases and can deliver certain vaccines. During 
cancer treatment they encapsule drugs, shielding healthy 
cells from their toxicity, and prevent their concentration in 
vulnerable tissues such as those of patient kidneys and liver. 
Liposomes can also reduce or eliminate certain common side 
effects of cancer treatment such as nausea and hair loss. 
They are form of vesicles that consist either of many, few or 
just one phospholipid bilayers. The polar character of 
liposomal core enables polar drug molecules to be 
encapsulated. Amphiphilic and lipophilic molecules are 
solubilized within phospholipid bilayer according to their 
affinity towards phospholipids.14 
Advantages of liposomes  
1. The high biocompatibility.  
2. The easiness of preparation.  
3. The chemical versatility that allows the loading of 
hydrophilic, amphiphilic, and lipophilic compounds.  
The simple modulation of their pharmacokinetic properties 
by changing the chemical composition of the bilayer 
components 15. 
Use of Liposomes  
Another major and important advancement in the novel drug 
delivery systems is the use of liposomes for carrying the 
drugs to the site of action. Liposomes in both modified and 
unmodified forms are able to change the course of 
pharmacokinetic parameters of the drugs. These are widely 
used in delivering the cytotoxic agents to the tumour tissue 
and preventing side effects like myelosuppression. These are 
also used in targeting through receptor-mediated 
endocytosis. Modified liposomes also have huge applications 
in targeting various drugs to the organs like heart, liver, 
kidney, lungs and bones 16 
NANOPARTICLES 
Nanoparticles (including nanospheres and nanocapsules of 
size 10-200 nm) are in the solid state and are either 
amorphous or crystalline. They are able to adsorb and/or 
encapsulate a drug, thus protecting it against chemical and 
enzymatic degradation. In recent years, biodegradable 
polymeric nanoparticles have attracted considerable 
attention as potential drug delivery devices in view of their 
applications in the controlled release of drugs, in targeting 
particular organs / tissues, as carriers of DNA in gene 
therapy, and in their ability to deliver proteins, peptides and 
genes through the peroralroute17,18 
Advantages of herbal nanoparticle delivery system  
1. Nanoparticulate system delivers the herbal formulation 
directly to the site of action.  
2. Increased efficacy and therapeutic index.  
3. Increased stability via encapsulation.  
4. Improved pharmacokinetic effect.  
5. Producible with various sizes, compound surface 
properties 19.  
EMULSIONS  
Emulsion is a biphasic system in which one phase is 
intimately disperses in the other phase in the form of minute 
droplets in ranging in diameter from 0.1μm to 100 μm. In 
emulsion, one phase is always water or aqueous phase, and 
the other phase is oily liquid, i.e. non aqueous. Among them, 
the microemulsion is also called nanoemulsion, and the sub-
micro-emulsion is called liquid emulsion 20. Microemulsion is 
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a clear, thermodyanamically stable, frequently in 
combination with a co-surfactant 21.  
Advantages of emulsion-based formulations  
1. It can release the drug for a long time because it is 
packed in the inner phase and makes direct.  
2. Contact with the body and other tissues.  
3. As a result of the lipophilic drugs being made into 
o/w/o emulsion, the droplets of oil are phagocytosised 
by macrophages and increase its concentration in liver, 
spleen and kidney.  
4. As the emulsion contains herbal formulation, it will 
increase the stability of hydrolyzed formulated 
material and improve the penetrability of drug into 
skin and mucous.  
5. The new type, viz., Elemenum emulsion, is used as an 
anti-cancer drug and causes no harm to the heart and 
liver 22.  
MICROSPHERES  
Microsphere comprises of small spherical particles, with 
diameters in the micrometer range, typically 1 μm to 1000 
μm (1 mm). Microspheres are sometimes referred to as 
micro-particles. Microspheres can be manufactured from 
various natural and synthetic materials. Glass microspheres, 
polymer microspheres and ceramic microspheres are 
commercially available. Microspheres are classified as 
biodegradable or non-biodegradable. Biodegradable 
microspheres include albumin microspheres, modified 
starch microspheres, gelatin microspheres, polypropylene 
dextranmicrospheres, polylactic acid microspheres, etc. 
According to the current literature reports on non-
biodegradable microspheres, polylactic acid is the only 
polymer approved to be used by people, and it is used as a 
controlled-release agent. Solid and hollow microspheres vary 
widely in density and therefore are used for different 
applications 23. 
ETHOSOMES 
Ethosomes are developed by mixture of phospholipids and 
high concentration of ethanol. This carrier can penetrate 
through the skin deeply lead to improve drug delivery into 
deeper layer of skin and in blood circulation. These 
formulations are useful for topical delivery of alkaloids in 
form of gel and cream for patients comfort. They show 
increase in their permeability through the skin by fluidizing 
the lipid domain of the skin. Unstable nature and poor skin 
penetration are limits for Ethanosomes tropical delivery. The 
Ethosomes was developed and examined for their ability the 
topical absorption of Tetrandine through dermal delivery, 
and the relation of formulations to the pharmacological 
activity of Tetrandrine loaded in the formulation was also 
accessed. Result of the drug levels in rat plasma showed that 
when Tetrandrineloded Ethosomes were topically 
administered in rats the drug level was low to be detected in 
rat plasmaIn conclusion, Ethosomes were demonstrated to 
be promising carrier for improving topical delivery of 
Tentrandrine via skin 24.  
Advantages of ethosomal drug delivery  
1. Ethosomes enhance transdermal permeation of drug 
through skin.  
2. Ethosomes are a platform for the delivery of large amounts 
of diverse groups of drugs.  
3. Ethosomal drug is administered in semisolid form 
resulting in improvement in patient’s compliance 25.  
SOLID LIPID NANOPARTICLES 
 (SLNs) are a new pharmaceutical delivery system or 
pharmaceutical formulation. 
The conventional approaches such as use of permeation 
enhancers, surface modification, prodrug synthesis, complex 
formation and colloidal lipid carrier based strategies have 
been developed for the delivery of drugs to intestinal 
lymphatics. In addition, polymeric nanoparticles, self-
emulsifying delivery systems, liposomes, microemulsions, 
micellar solutions and recently solid lipid nanoparticles 
(SLN) have been exploited as probable possibilities as 
carriers for oral intestinal lymphatic delivery.25 
A solid lipid nanoparticle is typically spherical with an 
average diameter between 10 and 1000 nanometers. Solid 
lipid nanoparticles possess a solid lipid core matrix that 
can solubilize lipophilic molecules. The lipid core is 
stabilized by surfactants (emulsifiers). The term lipid is used 
here in a broader sense and includes triglycerides (e.g. 
tristearin), diglycerides (e.g.glycerolbahenate), mono-
glycerides (e.g. glycerol monostearate), fatty acids 
(e.g. stearic acid), steroids (e.g. cholesterol), and waxes 
(e.g. cetylpalmitate). All classes of emulsifiers (with respect 
to charge and molecular weight) have been used to stabilize 
the lipid dispersion. It has been found that the combination 
of emulsifiers might prevent particle agglomeration more 
efficiently.26,27 
NIOSOMES 
Niosomes are multilamellar vesicles formed from non-ionic 
surfactants of the alkyl or dialkylpolyglycerol ether class and 
cholesterol. Earlier studies, in association with L'Oreal have 
shown that, in general, niosomes have properties as potential 
drug carriers similar to liposomes. Niosomes are different 
from liposomes in that they offer certain advantages over 
liposomes 28.  
PRONIOSOMES 
Proniosomes gel system is step forward to niosome, which 
can be utilized for various applications in delivery of actives 
at desire site. Proniosomal gels are the formulations, which 
on in situ hydration with water from the skin are converted 
into niosomes 29, 
DENDRIMERS 
Dendrimers are precisely defined, synthetic nanoparticles 
that are approximately 5–10 nm in diameter. They are made 
up of layers of polymer surrounding a control core. The 
dendrimers surface contains many different sites to which 
drugs may be attach and also attachment sites for materials 
such as PEG which can be used to modified the way of 
dendrimer which interacts with body. PEG can be attached to 
dendrimer to ‘disguise’ it and prevent the body’s defense 
mechanism for detecting it, there by slowing the process of 
break down. This fascinating particle holds significant 
promise for cancer treatment. Its many branches allow other 
molecules to easily attach to its surface. Researchers have 
fashioned dendrimers into sophisticated anticancer 
machines carrying five chemical tools – a molecule designed 
to bind to cancer cells, a second that fluorescence upon 
locating genetic mutations, a third to assist in imaging tumor 
shape using x – rays, a fourth carrying drugs released on 
demand, and a fifth that would send a signal when cancerous 
cells are finally dead. The creators of these dendrimers had 
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successful tests with cancer cells in culture and plan to try 
them in living animals soon30,31 
LIQUID CRYSTALS  
Liquid Crystals combine the properties of both liquid and 
solid states. They can be made to from different geometries, 
with alternative polar and non-polar layers (i.e., a lamellar 
phase) where aqueous drug solutions can be included 32.  
HYDROGELS  
Hydrogels are three-dimensional, hydrophilic, polymeric 
networks capable of imbibing large amounts of water or 
biological fluids. They are used to regulate drug release in 
reservoir-based, controlled release systems or as carriers in 




Figure 1: Structure of Liposome & Phytosome 
 
FUTURE PROSPECTS AND OPPORTUNITIES IN 
INDIA  
India is one of the most strategic regions for the 
pharmaceutical market. Therefore many multinational giants 
have been keen to invest and grow preferentially in this 
sector. Developments in the new and advanced techniques in 
the field of NDDS will create huge demand for variety of 
excipients usage and development. India is well known for its 
quick adaptability to new excipients and associated 
technologies. So market for excipients in India will grow on 
two aspects; one is in the form of exporting new organic 
excipients and the second one in the form of employing new 
excipients in various advanced delivery technologies. 
Majority of the pharmaceutical companies in the country 
have been applying and receiving new patents in the field of 
the Novel drug delivery systems. This eventually, in the near 
future derives huge demand for the products and services 
offered by pharmaceutical and allied businesses. 
Nanotechnology offers various modern applications in novel 
drug delivery systems that potentially improve the diagnosis, 
treatment and help monitoring of post-administration 
transformation of drug composition within the body systems. 
Another important milestone to be mentioned here is 
Computer aided Drug Design, which offers a lot of scope for 
the development of this kind of novel and advanced systems. 
Computer aided Drug Design helps in designing and 
developing the drugs and delivery systems consuming less 
time and resources with more accuracy and quality 
compared to traditional methods 34,35. 
MOLECULAR IMPRINTING TECHNOLOGY 
The molecular imprinting technology has an enormous 
potential for creating satisfactory drug dosage forms. 
Molecular imprinting involves forming a pre-polymerization 
complex between the template molecule and functional 
monomers or functional oligomers (or polymers) with 
specific chemical structures designed to interact with the 
template either by covalent, non-covalent chemistry (self-
assembly) or both. Once the pre-polymerization complex is 
formed, the polymerization reaction occurs in the presence 
of a cross-linking monomer and an appropriate solvent, 
which controls the overall polymer morphology and 
macroporous structure. Once the template is removed, the 
product is a heteropolymer matrix with specific recognition 
elements for the template molecule. Examples of MIP-based 
drug delivery systems involve: (i) rate-programmed drug 
delivery, where drug diffusion from the system has to follow 
a specific rate profile, (ii) activation-modulated drug 
delivery, where the release is activated by some physical, 
chemical or biochemical processes and (iii) feedback-
regulated drug delivery, where the rate of drug release is 
regulated by the concentration of a triggering agent, such as 
a biochemical Substance, the concentration of which is 
dependent on the drug concentration in the body. Despite 
the already developed interesting applications of MIPs, the 
incorporation of the molecular imprinting approach for the 
development of DDS is just at its incipient stage. 
Nevertheless, it can be foreseen that, in the next few years, 
significant progress will occur in this field, taking advantage 
of the improvements of this technology in other areas. 
Among the evolution lines that should contribute more to 
enhance the applicability of imprinting for drug delivery, the 
application of predictive tools for a rational design of 
imprinted systems and the development of molecular 
imprinting in water may be highlighted 36 
ADMINISTRATION ROUTES 
The choice of a delivery route is driven by patient 
acceptability, the properties of the drug (such as its 
solubility), access to a disease location, or effectiveness in 
dealing with the specific disease. The most important drug 
delivery route is the peroral route. An increasing number of 
drugs are protein and peptide based. They offer the greatest 
potential for more effective therapeutics, but they do not 
easily cross mucosal surfaces and biological membranes; 
they are easily denatured or degraded, prone to rapid 
clearance in the liver and other body tissues and require 
precise dosing. At present, protein drugs are usually 
administered by injection, but this route is less pleasant and 
also poses problems of oscillating blood drug concentrations. 
So, despite the barriers to successful drug delivery that exist 
in the gastrointestinal tract (i.e., acid-induced hydrolysis in 
the stomach, enzymatic degradation throughout the 
gastrointestinal tract by several proteolytic enzymes, 
bacterial fermentation in the colon), the peroral route is still 
the most intensively investigated as it offers advantages of 
convenience and cheapness of administration, and potential 
manufacturing cost savings. 
Pulmonary delivery is also important and is effected in a 
variety of ways - via aerosols, metered dose inhaler systems 
(MDIs), powders (dry powder inhalers, DPIs) and solutions 
(nebulizers), all of which may contain nanostructures such as 
liposomes, micelles, nanoparticles and dendrimers. Aerosol 
products for pulmonary delivery comprise more than 30% of 
the global drug delivery market. Research into lung delivery 
is driven by the potential for successful protein and peptide 
drug delivery, and by thepromise of an effective delivery 
mechanism for gene therapy (for example, in the treatment 
of cystic fibrosis), as well as the need to replace 
chlorofluorocarbon propellants in MDIs. Pulmonary drug 
delivery offers both local targeting for the treatment of 
respiratory diseases and increasingly appears to be a viable 
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option for the delivery of drugs systemically. However, the 
pulmonary delivery of proteins suffers by proteases in the 
lung, which reduce the overall bioavailability, and by the 
barrier between capillary blood and alveolar air (air-blood 
barrier). Transdermal drug delivery avoids problems such as 
gastrointestinal irritation, metabolism, variations in delivery 
rates and interference due to the presence of food. It is also 
suitable for unconscious patients. The technique is generally 
non-invasive and aesthetically acceptable, and can be used to 
provide local delivery over several days. Limitations include 
slow penetration rates, lack of dosage flexibility and / or 
precision, and a restriction to relatively low dosage drugs37. 
CONCLUSION 
Novel drug delivery system not only reduces the repeated 
administration to overcome noncompliance, but also helps to 
increase the therapeutic value by reducing toxicity and 
increasing the bioavailability, and so on. Extensive research 
is going on for herbal drugs to incorporate them in novel 
drug delivery systems. Application of these novel techniques 
to natural medicines will led to enhanced bioavailability, 
reduced toxicity, sustained release action, protection from GI 
degradation which cannot be obtained through conventional 
drug delivery system due to large molecular size, poor 
solubility, degradation of herbal medicines in 
Gastrointestinal media. 
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